• Thumbnail for Cediranib
    Cediranib (AZD-2171; tentative trade name Recentin) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. The...
    8 KB (644 words) - 19:21, 20 December 2023
  • concomitantly promote invasiveness and metastasis of tumours. AZ2171 (cediranib), a multi-targeted tyrosine kinase inhibitor has been shown to have anti-edema...
    14 KB (1,671 words) - 23:17, 4 September 2024
  • (INN) Ceclor Cecon Cedax cedefingol (INN) cedelizumab (INN) Cedilanid-D cediranib (USAN, INN) Cedocard-SR CeeBU (Bristol-Myers Squibb) Ceenu Ceepryn cefacetrile...
    10 KB (489 words) - 02:02, 1 July 2024
  • Thumbnail for Insulin
    Cyclotraxin B Kinase inhibitors: Agerafenib Altiratinib Axitinib Cabozantinib Cediranib Fruquintinib Lapatinib Lenvatinib Motesanib Nintedanib Pazopanib Pegaptanib...
    121 KB (13,799 words) - 17:37, 8 October 2024
  • Thumbnail for Amitriptyline
    Cyclotraxin B Kinase inhibitors: Agerafenib Altiratinib Axitinib Cabozantinib Cediranib Fruquintinib Lapatinib Lenvatinib Motesanib Nintedanib Pazopanib Pegaptanib...
    93 KB (8,729 words) - 21:31, 30 September 2024
  • Thumbnail for Cerebral edema
    side effects. Agents that target the VEGF signaling pathways, such as cediranib, have been promising in prolonging survival in rat models but associated...
    70 KB (7,820 words) - 06:59, 12 July 2024
  • Cyclotraxin B Kinase inhibitors: Agerafenib Altiratinib Axitinib Cabozantinib Cediranib Fruquintinib Lapatinib Lenvatinib Motesanib Nintedanib Pazopanib Pegaptanib...
    13 KB (1,177 words) - 02:19, 4 September 2024
  • Fedratinib L01EJ03 Pacritinib L01EJ04 Momelotinib L01EK01 Axitinib L01EK02 Cediranib L01EK03 Tivozanib L01EK04 Fruquintinib L01EL01 Ibrutinib L01EL02 Acalabrutinib...
    12 KB (877 words) - 15:36, 25 January 2024
  • Thumbnail for Amivantamab
    Cyclotraxin B Kinase inhibitors: Agerafenib Altiratinib Axitinib Cabozantinib Cediranib Fruquintinib Lapatinib Lenvatinib Motesanib Nintedanib Pazopanib Pegaptanib...
    24 KB (1,890 words) - 16:21, 4 October 2024
  • Thumbnail for Faricimab
    Cyclotraxin B Kinase inhibitors: Agerafenib Altiratinib Axitinib Cabozantinib Cediranib Fruquintinib Lapatinib Lenvatinib Motesanib Nintedanib Pazopanib Pegaptanib...
    20 KB (1,566 words) - 08:58, 12 August 2024